Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2), also known as MK2, is a serine/threonine-protein kinase that plays a central role in cellular responses to stress and inflammation. It is activated by p38 MAP kinase and regulates cytokine production, cell migration, and DNA damage repair. It has been implicated in cancer and inflammatory diseases and is a potential therapeutic target. Major substrates include HSP27, Cdc25B/C, and RNA-binding proteins ZFP36/tristetraprolin and ELAVL1/HuR.
Kinase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2).